Morgan Stanley Immuno Precise Antibodies Ltd. Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Morgan Stanley holds 10,000 shares of IPA stock, worth $15,700. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 12,533
20.21%
Holding current value
$15,700
Previous $4,000
150.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IPA
# of Institutions
26Shares Held
3.99MCall Options Held
77.9KPut Options Held
0-
Ingalls & Snyder LLC New York, NY2.78MShares$4.36 Million0.1% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA699KShares$1.1 Million0.0% of portfolio
-
Xtx Topco LTD London, X091.4KShares$143,4690.0% of portfolio
-
Two Sigma Investments, LP New York, NY90.9KShares$142,6420.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$64,6840.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $39M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...